Prognostic value of the Residual Cancer Burden index according to breast cancer subtype: Validation on a cohort of BC patients treated by neoadjuvant chemotherapy

INTRODUCTION: The Residual Cancer Burden (RCB) quantifies residual disease after neoadjuvant chemotherapy (NAC). Its predictive value has not been validated on large cohorts with long-term follow up. The objective of this work is to independently evaluate the prognostic value of the RCB index depend...

Descripción completa

Detalles Bibliográficos
Autores principales: Hamy, Anne-Sophie, Darrigues, Lauren, Laas, Enora, De Croze, Diane, Topciu, Lucian, Lam, Giang-Thanh, Evrevin, Clemence, Rozette, Sonia, Laot, Lucie, Lerebours, Florence, Pierga, Jean-Yves, Osdoit, Marie, Faron, Matthieu, Feron, Jean-Guillaume, Laé, Marick, Reyal, Fabien
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7313974/
https://www.ncbi.nlm.nih.gov/pubmed/32579551
http://dx.doi.org/10.1371/journal.pone.0234191

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7313974/
https://www.ncbi.nlm.nih.gov/pubmed/32579551
http://dx.doi.org/10.1371/journal.pone.0234191

Ejemplares similares